Hainan Shuangcheng Pharmaceuticals Co., Ltd. (SHE:002693)

China flag China · Delayed Price · Currency is CNY
8.58
-0.03 (-0.35%)
Apr 30, 2026, 3:04 PM CST
0.59%
Market Cap 3.56B
Revenue (ttm) 276.76M
Net Income (ttm) 19.04M
Shares Out 414.69M
EPS (ttm) 0.05
PE Ratio 171.60
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 13,306,300
Average Volume 11,425,966
Open 8.57
Previous Close 8.61
Day's Range 8.43 - 8.74
52-Week Range 6.36 - 9.52
Beta 0.40
RSI 54.74
Earnings Date Apr 18, 2026

About SHE:002693

Hainan Shuangcheng Pharmaceuticals Co., Ltd. provides peptide, lyophilized, oncology, oral dosage, and other injection cartridge pharmaceutical products worldwide. The company offers thymalfasin, thymapentin, bortezmib, paclitaxel, somatostatin, pantoprazole, epifibatide, bivalirudin, liraglutide, and exenatide and sodium ferulate for injections, as well as vitamin B6. Hainan Shuangcheng Pharmaceuticals Co., Ltd. was founded in 2000 and is based in Haikou, the People’s Republic of China. [Read more]

Sector Healthcare
Founded 2000
Employees 605
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002693
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.